SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $775,000 | +4.6% | 37,620 | +138.5% | 0.00% | – |
| Q2 2023 | $741,000 | +18.9% | 15,772 | +6.2% | 0.00% | – |
| Q1 2023 | $623,000 | -8.0% | 14,854 | -16.4% | 0.00% | – |
| Q4 2022 | $677,000 | +58.9% | 17,761 | +63.3% | 0.00% | – |
| Q3 2022 | $426,000 | -14.8% | 10,877 | -29.8% | 0.00% | – |
| Q2 2022 | $500,000 | -22.2% | 15,497 | -20.2% | 0.00% | – |
| Q1 2022 | $643,000 | -45.7% | 19,418 | -30.2% | 0.00% | – |
| Q4 2021 | $1,184,000 | +20.9% | 27,834 | +25.9% | 0.00% | – |
| Q3 2021 | $979,000 | -75.5% | 22,104 | -68.6% | 0.00% | -100.0% |
| Q2 2021 | $4,001,000 | +10.6% | 70,446 | +45.8% | 0.00% | 0.0% |
| Q1 2021 | $3,616,000 | -4.8% | 48,311 | +10.0% | 0.00% | 0.0% |
| Q4 2020 | $3,798,000 | -21.9% | 43,908 | -44.8% | 0.00% | -50.0% |
| Q3 2020 | $4,863,000 | +107.0% | 79,553 | +40.8% | 0.00% | +100.0% |
| Q2 2020 | $2,349,000 | +360.6% | 56,500 | +218.0% | 0.00% | – |
| Q1 2020 | $510,000 | -88.2% | 17,768 | -70.3% | 0.00% | -100.0% |
| Q4 2019 | $4,320,000 | +21.6% | 59,831 | +136.2% | 0.00% | +100.0% |
| Q3 2019 | $3,554,000 | -22.1% | 25,335 | +1.7% | 0.00% | -50.0% |
| Q2 2019 | $4,561,000 | +4.1% | 24,912 | -9.6% | 0.00% | 0.0% |
| Q1 2019 | $4,383,000 | +153.6% | 27,559 | +52.8% | 0.00% | +100.0% |
| Q4 2018 | $1,728,000 | -37.8% | 18,037 | -8.3% | 0.00% | 0.0% |
| Q3 2018 | $2,778,000 | +24.9% | 19,666 | +38.4% | 0.00% | 0.0% |
| Q2 2018 | $2,224,000 | +425.8% | 14,207 | +440.4% | 0.00% | – |
| Q1 2018 | $423,000 | -91.6% | 2,629 | -91.4% | 0.00% | -100.0% |
| Q4 2017 | $5,028,000 | +103.7% | 30,534 | -22.9% | 0.00% | +100.0% |
| Q3 2017 | $2,468,000 | +12240.0% | 39,612 | +16002.4% | 0.00% | – |
| Q2 2017 | $20,000 | -71.8% | 246 | -75.3% | 0.00% | – |
| Q1 2017 | $71,000 | -28.3% | 994 | -48.9% | 0.00% | – |
| Q4 2016 | $99,000 | +800.0% | 1,947 | +456.3% | 0.00% | – |
| Q1 2016 | $11,000 | -97.9% | 350 | -96.2% | 0.00% | – |
| Q4 2015 | $536,000 | +1476.5% | 9,211 | +1024.7% | 0.00% | – |
| Q3 2015 | $34,000 | -87.1% | 819 | -84.4% | 0.00% | – |
| Q1 2015 | $264,000 | +153.8% | 5,264 | +85.8% | 0.00% | – |
| Q4 2014 | $104,000 | – | 2,833 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 5,149,482 | $105,976,340 | 2.24% |
| Palo Alto Investors LP | 1,005,776 | $20,698,870 | 1.96% |
| Boxer Capital, LLC | 1,094,000 | $22,514,520 | 1.20% |
| Bellevue Group AG | 3,513,351 | $72,304,764 | 1.16% |
| PDT Partners, LLC | 181,625 | $3,737,843 | 0.47% |
| EASTERLY INVESTMENT PARTNERS LLC | 195,643 | $4,026,333 | 0.44% |
| Harvest Investment Services, LLC | 30,302 | $623,615 | 0.40% |
| Simplify Asset Management Inc. | 120,030 | $2,470,217 | 0.28% |
| SAMLYN CAPITAL, LLC | 739,867 | $15,226,463 | 0.25% |
| CAXTON ASSOCIATES LP | 68,035 | $1,400,160 | 0.19% |